|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02327 MEILLEUREHEALTH
Nominal 
0.229 +0.003 (+1.327%) | 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Turnover | 164,570 | 842.932% | 36,518 | 50,676 | 129,304 | 119,894 |
| Cost of Sales | (136,113) | 4034.660% | (13,887) | (21,771) | (51,214) | (53,133) |
| Gross Profit | 28,457 | 100.953% | 22,631 | 28,905 | 78,090 | 66,761 |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | 21,727 | 23,813 | 20,086 | 13,581 | |
| Change in FV & Impairment on Others | (386) | -16.269% | (854) | (20,224) | (3,962) | -- | |
| Profit / (Loss) on Disposal | 1,373 | -- | 8,558 | -- | 3,900 | 9,435 | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (3,101) | 184.757% | (4,116) | (3,016) | (4,353) | (14,774) | |
| Profit / (Loss) before Taxation | 30,189 | 89.784% | 30,537 | 45,401 | 52,983 | 25,385 | |
| Taxation | (1,855) | 143.119% | 7,461 | (13,356) | (14,493) | (7,605) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 10 | -23.077% | (15) | 435 | 2,340 | 42 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 28,344 | 87.003% | 37,983 | 32,480 | 40,830 | 17,822 | |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Net Finance Costs / (Income) | (9,874) | -1.506% | (20,013) | (11,751) | (7,416) | (15,460) |
| Depreciation & Amortisation | -- | -- | 1,097 | 1,631 | 2,639 | 3,852 |
| Directors' Emoluments | -- | -- | -- | 2,585 | 1,693 | 2,614 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 0.700 | 89.189% | 0.930 | 0.790 | 1.000 | 0.430 |
| DPS (cts) | 0.150 | -- | 0.550 | 0.400 | 0.400 | 1.600 |
| Dividend Payout Ratio (%) | 21.429% | -- | 59.140% | 50.633% | 40.000% | 372.093% |
| Cash flow per share ($) | -- | -- | (0.012) | 0.045 | (0.033) | 0.011 |
| NBV per share ($) | 0.321 | -- | 0.305 | 0.294 | 0.306 | 0.323 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 28,344 |
| %Change | 87.003% |
| EPS / (LPS) | HKD 0.007 |
| NBV Per Share ($) | HKD 0.321 |